
Liliana Di Nola Baron
Examiner (ID: 5333)
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 361 |
| Issued Applications | 209 |
| Pending Applications | 88 |
| Abandoned Applications | 63 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18391733
[patent_doc_number] => 20230159951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => DUAL BIFUNCTIONAL VECTORS FOR AAV PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 17/948868
[patent_app_country] => US
[patent_app_date] => 2022-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24951
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17948868
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/948868 | DUAL BIFUNCTIONAL VECTORS FOR AAV PRODUCTION | Sep 19, 2022 | Pending |
Array
(
[id] => 18391733
[patent_doc_number] => 20230159951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => DUAL BIFUNCTIONAL VECTORS FOR AAV PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 17/948868
[patent_app_country] => US
[patent_app_date] => 2022-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24951
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17948868
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/948868 | DUAL BIFUNCTIONAL VECTORS FOR AAV PRODUCTION | Sep 19, 2022 | Pending |
Array
(
[id] => 18065722
[patent_doc_number] => 20220396809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => ENGINEERED NEWCASTLE DISEASE VIRUS VECTOR AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/831894
[patent_app_country] => US
[patent_app_date] => 2022-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25944
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17831894
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/831894 | ENGINEERED NEWCASTLE DISEASE VIRUS VECTOR AND USES THEREOF | Jun 2, 2022 | Pending |
Array
(
[id] => 18109597
[patent_doc_number] => 20230002477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => METHOD FOR TREATING INFECTION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2)
[patent_app_type] => utility
[patent_app_number] => 17/745171
[patent_app_country] => US
[patent_app_date] => 2022-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6050
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17745171
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/745171 | METHOD FOR TREATING INFECTION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) | May 15, 2022 | Abandoned |
Array
(
[id] => 18020949
[patent_doc_number] => 20220372448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => CELL LINE AND PRODUCING METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/744324
[patent_app_country] => US
[patent_app_date] => 2022-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9913
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17744324
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/744324 | CELL LINE AND PRODUCING METHOD THEREOF | May 12, 2022 | Abandoned |
Array
(
[id] => 18160074
[patent_doc_number] => 20230026666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => ENGINEERED BACTERIOPHAGE T4 NANOPARTICLES AS A POTENTIAL TARGETED ACTIVATOR OF HIV-1 LATENCY IN CD4+ HUMAN T-CELLS
[patent_app_type] => utility
[patent_app_number] => 17/736181
[patent_app_country] => US
[patent_app_date] => 2022-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14529
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17736181
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/736181 | ENGINEERED BACTERIOPHAGE T4 NANOPARTICLES AS A POTENTIAL TARGETED ACTIVATOR OF HIV-1 LATENCY IN CD4+ HUMAN T-CELLS | May 3, 2022 | Pending |
Array
(
[id] => 18160074
[patent_doc_number] => 20230026666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => ENGINEERED BACTERIOPHAGE T4 NANOPARTICLES AS A POTENTIAL TARGETED ACTIVATOR OF HIV-1 LATENCY IN CD4+ HUMAN T-CELLS
[patent_app_type] => utility
[patent_app_number] => 17/736181
[patent_app_country] => US
[patent_app_date] => 2022-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14529
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17736181
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/736181 | ENGINEERED BACTERIOPHAGE T4 NANOPARTICLES AS A POTENTIAL TARGETED ACTIVATOR OF HIV-1 LATENCY IN CD4+ HUMAN T-CELLS | May 3, 2022 | Pending |
Array
(
[id] => 17981205
[patent_doc_number] => 20220347241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => PREPARATION OF PHAGE COCKTAIL AS THERAPEUTIC AGENT FOR COW MASTITIS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/690379
[patent_app_country] => US
[patent_app_date] => 2022-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3799
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17690379
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/690379 | PREPARATION OF PHAGE COCKTAIL AS THERAPEUTIC AGENT FOR COW MASTITIS AND USE THEREOF | Mar 8, 2022 | Abandoned |
Array
(
[id] => 17807737
[patent_doc_number] => 20220259572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => ADENO-ASSOCIATED VIRUS (AAV) PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 17/669033
[patent_app_country] => US
[patent_app_date] => 2022-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12410
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17669033
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/669033 | ADENO-ASSOCIATED VIRUS (AAV) PRODUCTION | Feb 9, 2022 | Pending |
Array
(
[id] => 17776831
[patent_doc_number] => 20220243180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => Multipurpose Compositions for Collecting and Transporting Biological Material
[patent_app_type] => utility
[patent_app_number] => 17/579054
[patent_app_country] => US
[patent_app_date] => 2022-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8851
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17579054
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/579054 | Multipurpose Compositions for Collecting and Transporting Biological Material | Jan 18, 2022 | Abandoned |
Array
(
[id] => 17657094
[patent_doc_number] => 20220177559
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => COMPOSITIONS AND METHODS TO TREAT VIRAL INFECTION AND CO-MORBIDITIES
[patent_app_type] => utility
[patent_app_number] => 17/544416
[patent_app_country] => US
[patent_app_date] => 2021-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20680
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17544416
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/544416 | Compositions and methods to treat viral infection and co-morbidities | Dec 6, 2021 | Issued |
Array
(
[id] => 19940484
[patent_doc_number] => 12312606
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-27
[patent_title] => Nucleic acid constructs for VA RNA transcription
[patent_app_type] => utility
[patent_app_number] => 17/500778
[patent_app_country] => US
[patent_app_date] => 2021-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 28233
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17500778
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/500778 | Nucleic acid constructs for VA RNA transcription | Oct 12, 2021 | Issued |
Array
(
[id] => 17483615
[patent_doc_number] => 20220091119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => Methods for the Diagnosis and Detection of Viral Analytes
[patent_app_type] => utility
[patent_app_number] => 17/448095
[patent_app_country] => US
[patent_app_date] => 2021-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8801
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17448095
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/448095 | Methods for the Diagnosis and Detection of Viral Analytes | Sep 19, 2021 | Abandoned |
Array
(
[id] => 18227888
[patent_doc_number] => 20230066882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => Stable Reporter Flavivirus
[patent_app_type] => utility
[patent_app_number] => 17/412900
[patent_app_country] => US
[patent_app_date] => 2021-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11137
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17412900
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/412900 | Stable Reporter Flavivirus | Aug 25, 2021 | Pending |
Array
(
[id] => 17828510
[patent_doc_number] => 20220265814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => RECOMBINANT ADENOVIRUS VACCINE FOR CORONA VIRUS DISEASE 19 AND COMBINATION THERAPY USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/408489
[patent_app_country] => US
[patent_app_date] => 2021-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4549
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17408489
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/408489 | RECOMBINANT ADENOVIRUS VACCINE FOR CORONA VIRUS DISEASE 19 AND COMBINATION THERAPY USING THE SAME | Aug 22, 2021 | Abandoned |
Array
(
[id] => 18657685
[patent_doc_number] => 20230303630
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => ADENO-ASSOCIATED VIRUS COMPOSITIONS HAVING PREFERRED EXPRESSION LEVELS
[patent_app_type] => utility
[patent_app_number] => 18/022056
[patent_app_country] => US
[patent_app_date] => 2021-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36743
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18022056
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/022056 | ADENO-ASSOCIATED VIRUS COMPOSITIONS HAVING PREFERRED EXPRESSION LEVELS | Aug 19, 2021 | Pending |
Array
(
[id] => 18657685
[patent_doc_number] => 20230303630
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => ADENO-ASSOCIATED VIRUS COMPOSITIONS HAVING PREFERRED EXPRESSION LEVELS
[patent_app_type] => utility
[patent_app_number] => 18/022056
[patent_app_country] => US
[patent_app_date] => 2021-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36743
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18022056
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/022056 | ADENO-ASSOCIATED VIRUS COMPOSITIONS HAVING PREFERRED EXPRESSION LEVELS | Aug 19, 2021 | Pending |
Array
(
[id] => 17627699
[patent_doc_number] => 20220162714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => METHOD, SYSTEM AND APPARATUS FOR DETECTION
[patent_app_type] => utility
[patent_app_number] => 17/400136
[patent_app_country] => US
[patent_app_date] => 2021-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16970
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17400136
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/400136 | METHOD, SYSTEM AND APPARATUS FOR DETECTION | Aug 11, 2021 | Abandoned |
Array
(
[id] => 17415202
[patent_doc_number] => 20220050106
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => METHODS AND KITS FOR DETECTING SARS-CORONAVIRUS-2 ANTIGEN
[patent_app_type] => utility
[patent_app_number] => 17/400086
[patent_app_country] => US
[patent_app_date] => 2021-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20029
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17400086
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/400086 | METHODS AND KITS FOR DETECTING SARS-CORONAVIRUS-2 ANTIGEN | Aug 10, 2021 | Pending |
Array
(
[id] => 17400910
[patent_doc_number] => 20220043000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => METHODS AND KITS FOR DETECTING SARS-COV-2 PROTEIN IN A SAMPLE
[patent_app_type] => utility
[patent_app_number] => 17/393824
[patent_app_country] => US
[patent_app_date] => 2021-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44406
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17393824
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/393824 | METHODS AND KITS FOR DETECTING SARS-COV-2 PROTEIN IN A SAMPLE | Aug 3, 2021 | Pending |